Cargando…
Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics
Aberrant DNA methylation, in particular promoter hypermethylation and transcriptional silencing of tumor suppressor genes, has an important role in the development of many human cancers, including renal cell carcinoma (RCC). Indeed, apart from mutations in the well studied von Hippel-Lindau gene (VH...
Autores principales: | Morris, Mark R, Maher, Eamonn R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092110/ https://www.ncbi.nlm.nih.gov/pubmed/20815920 http://dx.doi.org/10.1186/gm180 |
Ejemplares similares
-
Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management
por: Maher, Eamonn R.
Publicado: (2018) -
Methylation profiling and evaluation of demethylating therapy in renal cell carcinoma
por: Ricketts, Christopher J, et al.
Publicado: (2013) -
Crossing Paths in Human Renal Cell Carcinoma (hRCC)
por: Gallego, Guadalupe Aparicio, et al.
Publicado: (2012) -
Identification of Candidate Tumour Suppressor Genes Frequently Methylated in Renal Cell Carcinoma
por: Morris, Mark R., et al.
Publicado: (2010) -
The epigenetic landscape of clear-cell renal cell carcinoma
por: Kluzek, Katarzyna, et al.
Publicado: (2015)